{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T18:23:04Z","timestamp":1770488584703,"version":"3.49.0"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1097\/rlu.0000000000001580","type":"journal-article","created":{"date-parts":[[2017,2,14]],"date-time":"2017-02-14T11:51:44Z","timestamp":1487073104000},"page":"264-270","source":"Crossref","is-referenced-by-count":19,"title":["FDG PET\/CT Assesses the Risk of Femoral Pathological Fractures in Patients With Metastatic Breast Cancer"],"prefix":"10.1097","volume":"42","author":[{"given":"Gary A.","family":"Ulaner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra M.","family":"Zindman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junting","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tae Won B.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John H.","family":"Healey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-4-20210204","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.clon.2013.03.003","article-title":"Incidence of skeletal-related events over time from solid tumour bone metastases reported in randomised trials using bone-modifying agents","volume":"25","author":"Poon","year":"2013","journal-title":"Clin Oncol (R Coll Radiol"},{"key":"R2-4-20210204","doi-asserted-by":"crossref","first-page":"4081","DOI":"10.1245\/s10434-014-4002-1","article-title":"Surgical management of bone metastases: quality of evidence and systematic review","volume":"21","author":"Wood","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"R3-4-20210204","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1007\/s00520-008-0418-0","article-title":"Impact of skeletal complications on patients' quality of life, mobility, and functional independence","volume":"16","author":"Costa","year":"2008","journal-title":"Support Care Cancer"},{"key":"R4-4-20210204","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.breast.2014.05.023","article-title":"Bone health in breast cancer patients: a comprehensive statement by CECOG\/SAKK Intergroup","volume":"23","author":"Rordorf","year":"2014","journal-title":"Breast"},{"key":"R5-4-20210204","first-page":"244","article-title":"Metastatic disease of the femur: surgical treatment.","volume":"230-","author":"Ward","year":"2003","journal-title":"Clin Orthop Relat Res"},{"key":"R6-4-20210204","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.suronc.2013.02.008","article-title":"Insight opinion to surgically treated metastatic bone disease: Scandinavian Sarcoma Group Skeletal Metastasis Registry report of 1195 operated skeletal metastasis","volume":"22","author":"Ratasvuori","year":"2013","journal-title":"Surg Oncol"},{"key":"R7-4-20210204","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1097\/00003086-198912000-00027","article-title":"Metastatic disease in long bones. A proposed scoring system for diagnosing impending pathologic fractures","volume":"249","author":"Mirels","year":"1989","journal-title":"Clin Orthop Relat Res"},{"key":"R8-4-20210204","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1302\/0301-620X.86B4.14703","article-title":"Comparative analysis of risk factors for pathological fracture with femoral metastases","volume":"86","author":"Van der Linden","year":"2004","journal-title":"J Bone Joint Surg Br"},{"key":"R10-4-20210204","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s11999-015-4453-0","article-title":"CT-based structural rigidity analysis is more accurate than Mirels scoring for fracture prediction in metastatic femoral lesions","volume":"474","author":"Damron","year":"2016","journal-title":"Clin Orthop Relat Res"},{"key":"R11-4-20210204","doi-asserted-by":"crossref","first-page":"3440","DOI":"10.1200\/JCO.2007.11.2854","article-title":"Fusion of metabolic function and morphology: sequential [18F]fluorodeoxyglucose positron-emission tomography\/computed tomography studies yield new insights into the natural history of bone metastases in breast cancer","volume":"25","author":"Du","year":"2007","journal-title":"J Clin Oncol"},{"key":"R12-4-20210204","doi-asserted-by":"crossref","first-page":"3154","DOI":"10.1200\/JCO.2009.27.5743","article-title":"Integrated positron emission tomography\/computed tomography may render bone scintigraphy unnecessary to investigate suspected metastatic breast cancer","volume":"28","author":"Morris","year":"2010","journal-title":"J Clin Oncol"},{"key":"R13-4-20210204","doi-asserted-by":"crossref","first-page":"5454","DOI":"10.1002\/cncr.27579","article-title":"Standardized uptake value by positron emission tomography\/computed tomography as a prognostic variable in metastatic breast cancer","volume":"118","author":"Morris","year":"2012","journal-title":"Cancer"},{"key":"R14-4-20210204","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1002\/cam4.119","article-title":"Prognostic value of quantitative fluorodeoxyglucose measurements in newly diagnosed metastatic breast cancer","volume":"2","author":"Ulaner","year":"2013","journal-title":"Cancer Med"},{"key":"R16-4-20210204","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jbmr.1998","article-title":"Atypical subtrochanteric and diaphyseal femoral fractures: second report of a task force of the American Society for Bone and Mineral Research","volume":"29","author":"Shane","year":"2014","journal-title":"J Bone Miner Res"},{"key":"R17-4-20210204","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1002\/jbmr.253","article-title":"Atypical subtrochanteric and diaphyseal femoral fractures: report of a task force of the American Society for Bone and Mineral Research","volume":"25","author":"Shane","year":"2010","journal-title":"J Bone Miner Res"},{"key":"R18-4-20210204","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S1095-0397(99)00016-3","article-title":"Tumor treatment response based on visual and quantitative changes in global tumor glycolysis using PET-FDG imaging. The visual response score and the change in total lesion glycolysis","volume":"2","author":"Larson","year":"1999","journal-title":"Clin Positron Imaging"},{"key":"R19-4-20210204","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1001\/jama.289.11.1421","article-title":"Trends in incidence rates of invasive lobular and ductal breast carcinoma","volume":"289","author":"Li","year":"2003","journal-title":"JAMA"},{"key":"R20-4-20210204","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1038\/sj.bjc.6602787","article-title":"Clinical characteristics of different histologic types of breast cancer","volume":"93","author":"Li","year":"2005","journal-title":"Br J Cancer"},{"key":"R21-4-20210204","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1016\/j.breast.2015.07.008","article-title":"Clinical implications of the intrinsic molecular subtypes of breast cancer","volume":"24","author":"Prat","year":"2015","journal-title":"Breast"},{"key":"R22-4-20210204","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1007\/s00259-015-3080-z","article-title":"Appearance of untreated bone metastases from breast cancer on FDG PET\/CT: importance of histologic subtype","volume":"42","author":"Dashevsky","year":"2015","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R23-4-20210204","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.2967\/jnumed.115.161455","article-title":"Comparison of 18F-FDG PET\/CT for systemic staging of newly diagnosed invasive lobular carcinoma versus invasive ductal carcinoma","volume":"56","author":"Hogan","year":"2015","journal-title":"J Nucl Med"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000001580","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,24]],"date-time":"2022-07-24T03:34:55Z","timestamp":1658633695000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00003072-201704000-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000001580","relation":{},"ISSN":["0363-9762"],"issn-type":[{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]}}}